About The Study: This analysis found that the COVID-19 pandemic was associated with shifts in the focus of payments from pharmaceutical and medical device companies to physicians and teaching hospitals for research and an immediate and sustained decline in payments for marketing. Research payments were stable during the pandemic despite widespread clinical trial suspensions, which may reflect clinical trial adaptations, including virtual study visits and remote outcome measurement.

A price for CO2 can be both highly effective and socially just - if it's well designed. This is the result of a new study by the Potsdam Institute for Climate Impact Research (PIK) and the Mercator Research Institute on Global Commons and Climate Change (MCC). At the heart of the idea: a targeted return of the revenues from CO2 pricing, especially to poorer people who need relatively large amounts of energy and can do little about it. So far, political fears of social hardship and possible uproar stand against the increase of CO2 prices.

ONE OF THE WORLD’S BIGGEST CLIMATE CHALLENGES is decarbonizing fossil energy uses that cannot be directly electrified using renewable power. Among so-called “hard-to-abate” (HTA) sectors are major industries that rely on fossil fuels, either for high-temperature energy or for chemical feedstocks. New research published in Nature Energy examines how China—by far the largest producer of iron, steel, cement, and building materials—can potentially utilize clean hydrogen (“green” and “blue” hydrogen) to decarbonize HTA sectors, and aid in achieving its 2030 and 2060 decarbonization pledges.

A new academic study demonstrates for the first time that scheduling medical appointments later in the week increases patient attendance by over 10 per cent.